| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,789 |
4,251 |
$446K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,125 |
4,726 |
$272K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,512 |
2,806 |
$114K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
829 |
825 |
$69K |
| 99177 |
|
1,632 |
1,625 |
$55K |
| 92587 |
|
1,728 |
1,717 |
$52K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
621 |
620 |
$52K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
622 |
598 |
$50K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
3,425 |
3,386 |
$32K |
| 90461 |
|
1,071 |
1,066 |
$32K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
340 |
340 |
$31K |
| 99188 |
|
1,151 |
1,144 |
$30K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,150 |
2,100 |
$23K |
| 96127 |
|
1,546 |
1,514 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
728 |
707 |
$9K |
| 99401 |
|
263 |
261 |
$8K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
418 |
373 |
$7K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
207 |
206 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
275 |
275 |
$6K |
| 81002 |
|
1,863 |
1,841 |
$5K |
| 96160 |
|
1,158 |
1,152 |
$4K |
| 94760 |
|
1,608 |
1,406 |
$4K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
37 |
37 |
$3K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
417 |
371 |
$3K |
| 99051 |
|
159 |
157 |
$3K |
| 88738 |
|
397 |
392 |
$2K |
| 36416 |
|
255 |
254 |
$2K |
| 83655 |
|
121 |
121 |
$1K |
| 92567 |
|
115 |
112 |
$1K |
| 94761 |
|
330 |
297 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
42 |
40 |
$985.53 |
| 85018 |
|
382 |
380 |
$883.20 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
292 |
260 |
$718.69 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$615.84 |
| 96161 |
|
29 |
26 |
$111.94 |
| J7510 |
Prednisolone oral, per 5 mg |
12 |
12 |
$7.37 |